Matthew Louis Scherer, MD

Dr. Geirsson is a renowned cardiac surgeon and the Director of the Cardiovascular Institute and Director of the Surgical Heart Valve Program at NewYork-Presbyterian/Columbia University Irving Medical Center. With an upbringing and medical education in Iceland, he honed his skills in General Surgery at Yale University and Cardiothoracic Surgery at the University of Pennsylvania between 1998 and 2007. During his tenure at Yale as the Director of Minimally Invasive Cardiac Surgery from 2007 to 2013, he made significant contributions to the field. Dr. Geirsson then returned to Iceland from 2013 to 2016, serving as a Cardiothoracic Surgeon at Landspitali University Hospital in Reykjavik. Driven by his passion for innovative approaches, he returned to Yale in 2016 and was appointed as the Chief of the Division of Cardiac Surgery in 2017.Dr. Geirsson's clinical practice focuses on minimally invasive cardiac surgery and valve surgery, specializing in robotic mitral valve repair and aortic valve repair. He achieved notable milestones by performing the first minimally right thoracotomy mitral valve surgery at YNHH in 2009 and the first robotic mitral valve surgery at YNHH in 2018. Moreover, his research endeavors encompass both basic and clinical science, concentrating on mitral valve prolapse and aortic aneurysm disease.With his expertise, dedication, and commitment to advancing cardiac surgery, Dr. Geirsson continues to make significant contributions to the field and improve patient outcomes.

Dr. Raza is a Professor of Medicine and Director of the MDS Center at Columbia University in New York, NY. She started her research in Myelodysplastic Syndromes (MDS) in 1982 and moved to Rush University, Chicago, Illinois in 1992, where she was the Charles Arthur Weaver Professor in Oncology and Director, Division of Myeloid Diseases. The MDS Program, along with a Tissue Repository containing more than 50,000 samples from MDS and acute leukemia patients was successfully relocated to the University of Massachusetts in 2004 and to Columbia University in 2010.Before moving to New York, Dr. Raza was the Chief of Hematology Oncology and the Gladys Smith Martin Professor of Oncology at the University of Massachusetts in Worcester. She has published the results of her laboratory research and clinical trials in prestigious, peer-reviewed journals such as The New England Journal of Medicine, Nature, Blood, Cancer, Cancer Research, the British Journal of Hematology, Leukemia, and Leukemia Research. Dr. Raza serves on numerous national and international panels as a reviewer, consultant, and advisor and is the recipient of a number of awards.

Dr. Bret Taback is a nationally recognized surgical oncologist in the New York-Presbyterian/Columbia University Irving Medical Center department of surgery. Dr. Taback is a leader in the clinical management of melanoma, sarcoma and skin/soft tissue tumor surgery. Dr. Taback is the Director of the Melanoma and Sarcoma Program and Director of the Breast Surgery Fellowship. Dr. Taback received his MD degree at Tufts University School of Medicine in Boston , and completed his general surgery residency at Brown University, Rhode Island Hospital. During that time he completed a Basic Science Research Fellowship at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston. Following this, he completed a fellowship in Complex Surgical Oncology at the John Wayne Cancer Institute, Santa Monica, California. Dr. Taback is a member of a number of organizations and societies including Society of Surgical Oncology, American Society of Clinical Oncology and the American Association for Cancer Research. He is also a Fellow of the American College of Surgeons. He has published and authored numerous peer review manuscripts, abstracts and presentations, as well as book chapters over the years in notable publications such as Annals of Surgery, Annals of Surgical Oncology, Cancer Research, Clinical Cancer Research and the Journal of the National Cancer Institute. He is a clinical investigator with SWOG and Alliance for clinical trials. Dr. Taback has served on numerous hospital committees including tumor boards, Institutional Review Boards, Oncology Operations Council and is the American College of Surgeon’s Commission on Cancer Physician Liaison for NYP Hospital. Most recently, Dr. Taback is a noted Castle Connolly Top Doctor.